Vital decisions blue cross blue shield1/15/2024 ![]() ![]() There was a 29 percent drop in opioid prescriptions filled in 2017 compared to 2013.The rate declined to 5.9 in 2017, which was the first drop in the eight years BCBSA has measured diagnoses.** Opioid use disorder diagnoses stabilized in 2016, with 6.2 in 1,000 BCBS members diagnosed.The report, “The Opioid Epidemic in America: An Update,” represents a comprehensive study of medical claims from BCBS commercially-insured members using opioid painkillers, as well as those diagnosed with opioid use disorder over a five-year period.* Similarly, BCBS lowered opioid consumption by 26 percent for the Federal Employee Program in the same time period. In addition, the study shows a 29 percent decline in opioid prescriptions filled and a 25 percent decrease in the number of BCBS members who filled at least one opioid prescription in a year. According to a five-year study of medical claims, the most recent report showed that opioid use disorder diagnoses declined slightly in 2017. We worked with over 40 experts to develop a playbook that provides guidance on opioid stewardship and stand ready to partner with BCBS companies to help solve the nation’s pressing opioid problem.” said Shantanu Agrawal, MD, MPhil, president and CEO of the National Quality Forum.īCBSA also continues to analyze system-wide data through its Health of America Report series to inform the dialogue and solutions on the opioid epidemic. “We applaud BCBS companies for their leadership to advance quality opioid treatment. The hotline will be available to BCBS members and non-members.īlue Distinction® Centers for Substance Use Treatment and Recovery and the national hotline will be operational by January 2020. In addition, to provide resources for all Americans, the Board agreed to establish a national hotline to connect those in need with treatment centers. “Our goal is to assess the effectiveness of treatment options and close the gap in care to make a difference in not just our members’ lives, but the lives of all Americans.” “BCBS companies are deeply committed to improving how we care for those currently suffering from opioid use disorder,” said Scott Serota, president and CEO of BCBSA. As part of that commitment, BCBSA will launch Blue Distinction® Centers for Substance Use Treatment and Recovery to ensure members have access to the best clinical thinking and evidenced-based approaches in dealing with the long-term issues associated with opioid use disorder. More than half of treatment programs are not accredited by either, highlighting a major gap in ensuring quality treatment.Ĭomplementing local efforts to help members with opioid use disorder, the Blue Cross Blue Shield Association (BCBSA) Board of Directors at its June meeting agreed to advance nationally the safety and effectiveness of treatment for opioid use disorder. To find reliable support for these members – and all Americans suffering from opioid use disorder – BCBS companies will collaborate with experts and industry leaders to assess the effectiveness of treatment options and improve access to quality treatment services.Īccording to a 2013 National Survey of Substance Abuse Treatment Services, only 22 percent of treatment centers were accredited by the Commission on Accreditation of Rehabilitation Facilities (CARF) and only 19 percent were accredited by the Joint Commission. Capabilities & Initiatives Show Capabilities & Initiatives submenuĬhicago - Almost a quarter of a million Blue Cross and Blue Shield (BCBS) members were diagnosed with opioid use disorder in 2017.The BCBS System Show The BCBS System submenu.Individuals & Families Show Individuals & Families submenu.Member Services Show Member Services submenu. ![]()
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |